Company logo

LPCN - Lipocine Inc.

NASDAQ -> Healthcare -> Biotechnology
Salt Lake City, United States
Type: Equity

LPCN price evolution
LPCN
(in millions $) 30 Sep 2023 30 Jun 2023 31 Mar 2023 31 Jan 2023
Current assets
Cash $4.07 $5.01 $4.77 $3.15
Short term investments $19.78 $20.78 $24.1 $29.38
Net receivables $0.04 $0.02 $0.04 $0.08
Inventory
Total current assets $24.61 $27.08 $30.61 $34.14
Long term investments
Property, plant & equipment $0.11 $0.12 $0.13 $0.13
Goodwill & intangible assets
Total noncurrent assets $0.14 $3.4 $3.41 $3.41
Total investments $19.78 $20.78 $24.1 $29.38
Total assets $24.75 $30.48 $34.02 $37.54
Current liabilities
Accounts payable $1.1 $0.52 $0.8 $0.6
Deferred revenue
Short long term debt
Total current liabilities $2.24 $1.83 $1.93 $1.68
Long term debt
Total noncurrent liabilities $0.03 $0.1 $0.13 $0.23
Total debt
Total liabilities $2.27 $1.93 $2.06 $1.91
Shareholders' equity
Retained earnings -$197.49 -$190.84 -$187.3 -$183.43
Other shareholder equity -$0.01 -$0.02 $0 -$0.02
Total shareholder equity $22.48 $28.55 $31.96 $35.63
(in millions $) 31 Jan 2023 31 Dec 2021 31 Dec 2020 31 Dec 2019
Current assets
Cash $3.15 $2.95 $24.22 $14.73
Short term investments $29.38 $41.67 $0.45 $4.34
Net receivables $0.08 $0.25 $0 $0.02
Inventory
Total current assets $34.14 $46.38 $25.33 $19.63
Long term investments $2.02
Property, plant & equipment $0.13 $0.01 $0
Goodwill & intangible assets
Total noncurrent assets $3.41 $6.1 $0.02 $0.03
Total investments $29.38 $43.69 $0.45 $4.34
Total assets $37.54 $52.48 $25.35 $19.66
Current liabilities
Accounts payable $0.6 $1.29 $1.6 $1.18
Deferred revenue
Short long term debt $2.31 $3.33 $3.33
Total current liabilities $1.68 $5.62 $6.58 $4.96
Long term debt $2.26 $3.81
Total noncurrent liabilities $0.23 $1.3 $3.43 $8.41
Total debt $2.31 $5.59 $7.15
Total liabilities $1.91 $6.91 $10.01 $13.37
Shareholders' equity
Retained earnings -$183.43 -$172.67 -$172.03 -$151.07
Other shareholder equity -$0.02 -$0.02 -$0.04 -$0
Total shareholder equity $35.63 $45.57 $15.34 $6.29
(in millions $) 30 Sep 2023 30 Jun 2023 31 Mar 2023 31 Dec 2022
Revenue
Total revenue -$3.12 $0.05
Cost of revenue
Gross Profit -$3.12 $0.05
Operating activities
Research & development $2.88 $2.52 $3.11 $1.67
Selling, general & administrative $1.04 $1.44 $1.29 $0.89
Total operating expenses $3.92 $3.96 $4.39 $2.56
Operating income -$7.04 -$3.96 -$4.34 -$2.56
Income from continuing operations
EBIT -$6.65 -$3.55 -$3.87 -$2.23
Income tax expense $0 $0
Interest expense
Net income
Net income -$6.65 -$3.55 -$3.87 -$2.23
Income (for common shares) -$6.65 -$3.55 -$3.87 -$2.23
(in millions $) 31 Dec 2022 31 Dec 2021 31 Dec 2020 31 Dec 2019
Revenue
Total revenue $0.5 $16.14 $0.16
Cost of revenue
Gross Profit $0.5 $16.14 $0.16
Operating activities
Research & development $8.56 $7.67 $9.75 $7.47
Selling, general & administrative $4.06 $5.33 $8.25 $5.6
Total operating expenses $12.62 $13 $18 $13.07
Operating income -$12.12 $3.15 -$18 -$12.9
Income from continuing operations
EBIT -$10.73 -$0.43 -$20.58 -$13.01
Income tax expense $0 $0 $0 $0
Interest expense $0.03 $0.2 $0.39
Net income
Net income -$10.76 -$0.63 -$20.96 -$13.01
Income (for common shares) -$10.76 -$0.63 -$20.96 -$13.01
(in millions $) 30 Sep 2023 30 Jun 2023 31 Mar 2023 31 Dec 2022
Net income -$6.65 -$3.55 -$3.87 -$2.23
Operating activities
Depreciation $0.01 $0.01 $0 $0
Business acquisitions & disposals
Stock-based compensation $0.16 $0.16 $0.18 $0.17
Total cash flows from operations -$2.61 -$3.31 -$3.93 -$1.84
Investing activities
Capital expenditures -$0 -$0.1
Investments $1.24 $3.56 $5.56 $2.69
Total cash flows from investing $1.24 $3.56 $5.55 $2.6
Financing activities
Dividends paid
Sale and purchase of stock $0.41 -$0.01
Net borrowings
Total cash flows from financing $0.42 -$0.01 -$0.01 -$0.01
Effect of exchange rate
Change in cash and equivalents -$0.94 $0.25 $1.62 $0.75
(in millions $) 31 Dec 2022 31 Dec 2021 31 Dec 2020 31 Dec 2019
Net income -$10.76 -$0.63 -$20.96 -$13.01
Operating activities
Depreciation $0.01 $0 $0 $0.02
Business acquisitions & disposals
Stock-based compensation $0.64 $0.6 $1.37 $1.04
Total cash flows from operations -$11.97 -$4.41 -$15.3 -$11.67
Investing activities
Capital expenditures -$0.13 -$0.01
Investments $14.43 -$43.77 $3.89 $3
Total cash flows from investing $14.29 -$43.78 $3.89 $3
Financing activities
Dividends paid
Sale and purchase of stock $0.19 $30.26 $22.33 $13.65
Net borrowings -$2.32 -$3.33 -$1.43 -$3.33
Total cash flows from financing -$2.13 $26.92 $20.9 $10.32
Effect of exchange rate
Change in cash and equivalents $0.2 -$21.27 $9.49 $1.65
Fundamentals
Market cap $20.54M
Enterprise value $16.46M
Shares outstanding 5.32M
Revenue -$3.07M
EBITDA -$16.28M
EBIT -$16.30M
Net Income -$16.30M
Revenue Q/Q -InfinityT%
Revenue Y/Y -118.49%
P/E ratio -1.26
EV/Sales -5.37
EV/EBITDA -1.01
EV/EBIT -1.01
P/S ratio -6.70
P/B ratio 0.91
Book/Share 4.23
Cash/Share 0.77
EPS -$3.06
ROA -51.42%
ROE -54.96%
Debt/Equity 0.05
Net debt/EBITDA 0.11
Current ratio 10.98
Quick ratio 10.98